Answers are grounded in this paper and cite their sources.
Investigative work reveals microglial dysfunction mitigation through a lipid-lowering nanotherapeutic, suggesting new treatment possibilities.
PB integrates mesoporous lipid adsorption, intrinsic redox buffering, and berberine loading, thereby attenuating oxidative stress and mitochondrial injury associated with lipid overload in microglia. This work highlights the potential of lipid-lowering nanotherapeutic strategies for intervening in lipid-overload-associated microglial dysfunction.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: